Inhibition of diacylglycerol lipase β modulates lipid and endocannabinoid levels in the

2-arachidonoylglycerol activity-based protein profiling chemical proteomics diacylglycerol lipase endocannabinoid system ex vivo placental perfusion human placenta lipid metabolism

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 07 11 2022
accepted: 27 01 2023
entrez: 3 3 2023
pubmed: 4 3 2023
medline: 7 3 2023
Statut: epublish

Résumé

Lipids and fatty acids are key components in metabolic processes of the human placenta, thereby contributing to the development of the fetus. Placental dyslipidemia and aberrant activity of lipases have been linked to diverse pregnancy associated complications, such as preeclampsia and preterm birth. The serine hydrolases, diacylglycerol lipase α and β (DAGLα, DAGLβ) catalyze the degradation of diacylglycerols, leading to the formation of monoacylglycerols (MAG), including one main endocannabinoid 2-arachidonoylglycerol (2-AG). The major role of DAGL in the biosynthesis of 2-AG is evident from various studies in mice but has not been investigated in the human placenta. Here, we report the use of the small molecule inhibitor DH376, in combination with the ex vivo placental perfusion system, activity-based protein profiling (ABPP) and lipidomics, to determine the impact of acute DAGL inhibition on placental lipid networks. DAGLα and DAGLβ mRNA expression was detected by RT-qPCR and in situ hybridization in term placentas. Immunohistochemistry staining for CK7, CD163 and VWF was applied to localize DAGLβ transcripts to different cell types of the placenta. DAGLβ activity was determined by in- gel and MS-based activity-based protein profiling (ABPP) and validated by addition of the enzyme inhibitors LEI-105 and DH376. Enzyme kinetics were measured by EnzChek™ lipase substrate assay. We demonstrate that mRNA expression of DAGLβ prevails in placental tissue, compared to DAGLα (p ≤ 0.0001) and that DAGLβ is mainly located to CK7 positive trophoblasts (p ≤ 0.0001). Although few DAGLα transcripts were identified, no active enzyme was detected applying in-gel or MS-based ABPP, which underlined that DAGLβ is the principal DAGL in the placenta. DAGLβ dependent substrate hydrolysis in placental membrane lysates was determined by the application of LEI-105 and DH376. Our results emphasize the role of DAGLβ activity in the human placenta by determining the biosynthesis of 2-AG. Thus, this study highlights the special importance of intra-cellular lipases in lipid network regulation. Together, the activity of these specific enzymes may contribute to the lipid signaling at the maternal-fetal interface, with implications for function of the placenta in normal and compromised pregnancies.

Identifiants

pubmed: 36864832
doi: 10.3389/fendo.2023.1092024
pmc: PMC9971001
doi:

Substances chimiques

Endocannabinoids 0
Fatty Acids 0
Hydrolases EC 3.-
Lipoprotein Lipase EC 3.1.1.34
RNA, Messenger 0
Serine 452VLY9402

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1092024

Subventions

Organisme : Austrian Science Fund FWF
ID : DOC 31
Pays : Austria

Informations de copyright

Copyright © 2023 Berger, van der Wel, Hirschmugl, Baernthaler, Gindlhuber, Fawzy, Eichmann, Birner-Gruenberger, Zimmermann, van der Stelt and Wadsack.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Obes (Lond). 2021 May;45(5):1114-1123
pubmed: 33637949
J Cell Biol. 2003 Nov 10;163(3):463-8
pubmed: 14610053
Nat Chem Biol. 2012 Dec;8(12):999-1007
pubmed: 23103940
J Clin Endocrinol Metab. 2004 Nov;89(11):5482-7
pubmed: 15531501
Cell Chem Biol. 2020 Mar 19;27(3):314-321.e5
pubmed: 31991095
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2238-42
pubmed: 9122178
J Physiol. 2013 Oct 1;591(19):4765-76
pubmed: 23858009
Int J Mol Sci. 2020 Dec 17;21(24):
pubmed: 33348841
J Am Chem Soc. 2015 Jul 15;137(27):8851-7
pubmed: 26083464
Prostaglandins Other Lipid Mediat. 2018 Nov;139:19-23
pubmed: 30248406
Angew Chem Int Ed Engl. 2013 Nov 11;52(46):12081-5
pubmed: 24173880
ACS Chem Biol. 2018 Sep 21;13(9):2406-2413
pubmed: 30199617
Anal Chem. 2010 Aug 15;82(16):6790-6
pubmed: 20704368
Mol Hum Reprod. 2002 Feb;8(2):188-95
pubmed: 11818522
J Nutr. 2005 Nov;135(11):2566-71
pubmed: 16251612
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Dec;1865(12):158807
pubmed: 32829065
Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):26-33
pubmed: 26668358
PLoS One. 2018 Dec 21;13(12):e0209579
pubmed: 30576377
Acta Physiol (Oxf). 2012 Feb;204(2):267-76
pubmed: 21418147
J Clin Endocrinol Metab. 2007 Jun;92(6):2256-63
pubmed: 17356047
J Reprod Fertil. 1981 May;62(1):305-15
pubmed: 7230133
J Lipid Res. 2008 May;49(5):1137-46
pubmed: 18281723
Mol Cell Neurosci. 1996 Aug;8(2/3):120-8
pubmed: 8954627
Placenta. 2013 Jan;34(1):67-74
pubmed: 23122699
Endocrinology. 2010 Mar;151(3):921-8
pubmed: 20133454
PLoS One. 2016 Sep 29;11(9):e0163972
pubmed: 27685997
J Neurosci. 2010 Feb 10;30(6):2017-24
pubmed: 20147530
Chem Biol. 2007 Dec;14(12):1347-56
pubmed: 18096503
Contrib Gynecol Obstet. 1985;13:40-7
pubmed: 3995981
BMC Pregnancy Childbirth. 2014 Jul 22;14:241
pubmed: 25048443
Sci Rep. 2017 Aug 4;7(1):7363
pubmed: 28779174
J Lipid Res. 2005 Nov;46(11):2339-46
pubmed: 16150822
Cell Mol Life Sci. 2015 Oct;72(20):3931-52
pubmed: 26153463
Elife. 2016 Jan 18;5:e12345
pubmed: 26779719
Reproduction. 2016 Jun;151(6):R91-R102
pubmed: 26908920
Reproduction. 2014 Feb 03;147(3):301-11
pubmed: 24324206
Nutrients. 2021 Jun 16;13(6):
pubmed: 34208549
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1500-5
pubmed: 23297193
BMC Pregnancy Childbirth. 2014 Dec 02;14:395
pubmed: 25444073
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
Nat Neurosci. 2008 Feb;11(2):152-9
pubmed: 18204441
Nat Protoc. 2018 Apr;13(4):752-767
pubmed: 29565900
Cell Chem Biol. 2019 Jul 18;26(7):1036-1041.e3
pubmed: 31105063

Auteurs

Natascha Berger (N)

Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.

Tom van der Wel (T)

Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University and Oncode Institute, Leiden, Netherlands.

Birgit Hirschmugl (B)

Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.
BioTechMed-Graz, Graz, Austria.

Thomas Baernthaler (T)

Otto Loewi Research Center, Division of Pharmacology, University of Graz, Graz, Austria.

Juergen Gindlhuber (J)

Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Diagnostic and Research Center of Molecular Medicine, Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.

Nermeen Fawzy (N)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Thomas Eichmann (T)

BioTechMed-Graz, Graz, Austria.
Core Facility Mass Spectrometry, Center for Medical Research (ZMF), Medical University of Graz, Graz, Austria.

Ruth Birner-Gruenberger (R)

Diagnostic and Research Center of Molecular Medicine, Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Institute of Chemical Technologies and Analytics, Vienna University of Technology, Vienna, Austria.

Robert Zimmermann (R)

BioTechMed-Graz, Graz, Austria.
Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Mario van der Stelt (M)

Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University and Oncode Institute, Leiden, Netherlands.

Christian Wadsack (C)

Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.
BioTechMed-Graz, Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH